ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2022, Vol. 31 ›› Issue (1): 73-77.DOI: 10.3969/j.issn.1006-298X.2022.01.015

• • 上一篇    下一篇

慢性肾脏病血管钙化的生物标志物

  

  • 出版日期:2022-02-28 发布日期:2022-02-18

Biomarkers of vascular calcification in patients with chronic kidney disease

  • Online:2022-02-28 Published:2022-02-18

摘要: 血管钙化是慢性肾脏病(CKD)最常见的并发症之一,是影响CKD患者预后的主要因素。血管钙化的早期诊断、及时干预和进展评估对于改善预后至关重要。近些年,人们对于血管钙化生物标志物进行了大量研究,并且获得了显著的成果。本文将对基质γ羧基谷氨酸蛋白(MGP)、骨钙素(OC)、焦磷酸盐(PPi)、骨保护素(OPG)、成纤维细胞生长因子23(FGF23)、Klotho蛋白、钙蛋白颗粒(CPP)、骨硬化蛋白、 Dickkopf1(Dkk1)等血管钙化生物标志物的临床研究进行阐述,为CKD血管钙化的临床诊断与预后评估提供参考。


关键词: 慢性肾脏病,血管钙化,生物标志物

Abstract: Vascular calcification is one of the most common complications and the main factor affecting prognosis of patients with chronic kidney disease. Early diagnosis, accurate evaluation and timely intervention on vascular calcification are crucial to improve prognosis of vascular calcification patients. A number of studies on serum biomarkers of vascular calcification were performed and got hopeful results. The current manuscript will review some biomarkers, such as matrix GlaProtein(MGP),osteocalcin(OC),pyrophosphate(PPi),osteoprotegerin(OPG),fibroblast growth factor23(FGF23),klotho protein, calciprotein particle(CCP),sclerostin and dickkopf1 (Dkk1), in order to provide significance for diagnosis and treatment of vascular calcification in patients with chronic kidney disease.


Key words: chronic kidney disease,vascular calcification,biomarkers